ChemoMetec A/S updated earnings guidance for the fiscal year 2022/2023. For the year, the company expected revenue of DKK 430 million - DKK 460 million, against the previous guidance of DKK 485 million-DKK 505 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
290 DKK | -1.63% | -0.41% | -25.26% |
Apr. 12 | Chemometec A/S Reports Revenue for the Third Quarter and First Nine Months of 2023 -2024 | CI |
Apr. 12 | ChemoMetec A/S Provides Earnings Guidance for the Year 2023/24 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.26% | 735M | |
+73.54% | 12.37B | |
-18.54% | 7.96B | |
+15.29% | 7.09B | |
+3.39% | 5.83B | |
+11.77% | 5.35B | |
+29.65% | 4.63B | |
-17.74% | 4B | |
-34.95% | 2.41B | |
+2.10% | 2B |
- Stock Market
- Equities
- CHEMM Stock
- News ChemoMetec A/S
- ChemoMetec A/S Updates Earnings Guidance for the Fiscal Year 2022/2023